Related Experiment Video
Updated: Sep 26, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Prader-Willi Syndrome and PCSK1 mutation: a novel presentation of combined syndromic and monogenic obesity
E Kostopoulou1, D X Spilioti, N D Pantzaris
1Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, University of Patras School of Medicine, Patras, Greece. spilioti@upatras.gr.
Insights
Prader-Willi syndrome (PWS) patients may have PCSK1 gene mutations, not just chromosomal abnormalities. Investigating PCSK1 mutations could offer new treatment options for PWS.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- Prader-Willi syndrome (PWS) is a genetic imprinting disorder linked to chromosome 15q11.2-q13 deletions.
- The PCSK1 gene is crucial for processing POMC in the hypothalamus, regulating appetite and energy expenditure.
- The melanocortin-4 receptor (MC4R) pathway is a key target for managing obesity.
Observation:
- A 27-year-old male with PWS presented with severe obesity, hyperphagia, and other endocrine and sleep disturbances.
- Initial genetic testing at age 6 confirmed PWS due to a 15q11q13 deletion.
- Further genetic analysis at age 27 revealed a PCSK1 gene mutation (PCSK1_pN221D_HET).
Findings:
- Next-generation sequencing identified a heterozygous PCSK1_pN221D_HET mutation in the PWS patient.
- This mutation affects the function of the PCSK1 gene, which is vital for hormone processing.
- The study highlights the potential for diverse genetic causes within PWS.
Implications:
- PWS patients may harbor additional genetic defects beyond the typical 15q11q13 deletion.
- Investigating PCSK1 mutations in PWS could reveal new therapeutic targets.
- This research opens avenues for personalized treatment strategies in PWS management.
Objective:
Prader-Willi syndrome (PWS) is a genomic imprinting disorder predominantly caused by the absence of paternally expressed imprinted genes at chromosome 15q11.2-q13. The PCSK1 gene is vital for the processing of hypothalamic POMC to ACTH and α-MSH, leading to food intake suppression and increased energy expenditure. The aim of this study was to investigate whether our PWS patient had a defect in genes involved in the hypothalamic melanocortin-4 receptor (MC4R) pathway.
Patients And Methods:
A 27-year-old Greek man with PWS presented to the Adult Endocrine Clinic with morbid obesity and hyperphagia. He also had obstructive sleep apnea, growth hormone deficiency, gonadal failure and metabolic disturbances. At 6 years of age, chromosomal testing confirmed PWS with a deletion in the q11q13 region of the long arm of paternal chromosome 15.
Results:
At the age of 27 years, further genetic testing was conducted, and next generation sequencing revealed a PCSK1_pN221D_HET mutation which was confirmed by Sanger sequencing.
Conclusions:
Our findings suggest that different genetic abnormalities may be present in an individual with PWS and that patients with PWS may need to be investigated for PCSK1 mutations, as the finding may potentially offer a novel treatment perspective for them.
More Related Videos
Related Concept Videos
Inborn Errors of Metabolism
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pleiotropy
Obesity
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

